![FILE PHOTO: A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia June 11, 2020. REUTERS/Anton Vaganov/File Photo](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/MTNALV4CH33U3QQJBDEOHCM52I.jpg?smart=true&auth=4f01d647444a8e4ca5b2a99f8bb485dad52feac9387fe6f8127193d0cf2391b7&width=400&height=225)
The trial involved 76 healthy adults aged 18-60. Reuters
The trial involved 76 healthy adults aged 18-60. Reuters
Russian Covid-19 vaccine induces antibody response
Results published in ‘The Lancet’ medical journal also showed no serious side effects, although trials have been small